| Trial ID: | L0428 |
| Source ID: | ChiCTR2000033099
|
| Associated Drug: |
Sancailianmei Particle
|
| Title: |
Efficacy and safety of the Sancailianmei Particle in patients with type 2 diabetes and nonalcoholic fatty liver disease: an open-label, randomised controlled trial
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Type 2 diabetes combined with nonalcoholic fatty liver disease
|
| Interventions: |
experimental group:Sancailianmei Particle and standard treatment;control group:Standard treatment;
|
| Outcome Measures: |
Fibroscan Index;MIR-PDFF Index;body fat indexes;AGEs;P?P;nan
|
| Sponsor/Collaborators: |
Hospital of Chengdu University of Traditional Chinese Medicine
|
| Gender: |
All
|
| Age: |
1875
|
| Phases: |
Phase 0
|
| Enrollment: |
experimental group:30;control group:30;
|
| Study Type: |
Interventional study
|
| Study Designs: |
Parallel
|
| Start Date: |
20/05/2020
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
25 May 2020
|
| Locations: |
China
|
| URL: |
http://www.chictr.org.cn/showproj.aspx?proj=53647
|
